United States Venous Thromboembolism Market Report 2016

October 2016 | 122 pages | ID: U3DB67C2203EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Venous Thromboembolism

Revenue, means the sales value of Venous Thromboembolism

This report studies sales (consumption) of Venous Thromboembolism in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Pfizer, Inc. (US)
• Bayer Healthcare AG (Germany)
• GlaxoSmithKline Plc. (UK)
• Boehringer Ingelheim (Germany)
• Sanofi S.A. (France)
• Abbott India Limited (India)
• Aspen Holdings (South Africa)
• Bristol-Myers Squibb Company (US)
• Eisai Inc. (US)
• Mitsubishi Tanabe Pharma Corporation (Japan)
• Teva Pharmaceutical Industries Ltd. (Israel)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Type I
• Type II
• Type III

Split by applications, this report focuses on sales, market share and growth rate of Venous Thromboembolism in each application, can be divided into

• Application 1
• Application 2
• Application 3

Contents

United States Venous Thromboembolism Market Report 2016

1 VENOUS THROMBOEMBOLISM OVERVIEW

1.1 Product Overview and Scope of Venous Thromboembolism
1.2 Classification of Venous Thromboembolism
  1.2.1 Type I
  1.2.2 Type II
  1.2.3 Type III
1.3 Application of Venous Thromboembolism
  1.3.1 Application
  1.3.2 Application
  1.3.3 Application
1.4 United States Market Size Sales (Value) and Revenue (Volume) of Venous Thromboembolism (2011-2021)
  1.4.1 United States Venous Thromboembolism Sales and Growth Rate (2011-2021)
  1.4.2 United States Venous Thromboembolism Revenue and Growth Rate (2011-2021)

2 UNITED STATES VENOUS THROMBOEMBOLISM COMPETITION BY MANUFACTURERS

2.1 United States Venous Thromboembolism Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Venous Thromboembolism Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Venous Thromboembolism Average Price by Manufactures (2015 and 2016)
2.4 Venous Thromboembolism Market Competitive Situation and Trends
  2.4.1 Venous Thromboembolism Market Concentration Rate
  2.4.2 Venous Thromboembolism Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES VENOUS THROMBOEMBOLISM SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

3.1 United States Venous Thromboembolism Sales and Market Share by Type (2011-2016)
3.2 United States Venous Thromboembolism Revenue and Market Share by Type (2011-2016)
3.3 United States Venous Thromboembolism Price by Type (2011-2016)
3.4 United States Venous Thromboembolism Sales Growth Rate by Type (2011-2016)

4 UNITED STATES VENOUS THROMBOEMBOLISM SALES (VOLUME) BY APPLICATION (2011-2016)

4.1 United States Venous Thromboembolism Sales and Market Share by Application (2011-2016)
4.2 United States Venous Thromboembolism Sales Growth Rate by Application (2011-2016)
4.3 Market Drivers and Opportunities

5 UNITED STATES VENOUS THROMBOEMBOLISM MANUFACTURERS PROFILES/ANALYSIS

5.1 Pfizer, Inc. (US)
  5.1.1 Company Basic Information, Manufacturing Base and Competitors
  5.1.2 Venous Thromboembolism Product Type, Application and Specification
    5.1.2.1 Type I
    5.1.2.2 Type II
  5.1.3 Pfizer, Inc. (US) Venous Thromboembolism Sales, Revenue, Price and Gross Margin (2011-2016)
  5.1.4 Main Business/Business Overview
5.2 Bayer Healthcare AG (Germany)
  5.2.2 Venous Thromboembolism Product Type, Application and Specification
    5.2.2.1 Type I
    5.2.2.2 Type II
  5.2.3 Bayer Healthcare AG (Germany) Venous Thromboembolism Sales, Revenue, Price and Gross Margin (2011-2016)
  5.2.4 Main Business/Business Overview
5.3 GlaxoSmithKline Plc. (UK)
  5.3.2 Venous Thromboembolism Product Type, Application and Specification
    5.3.2.1 Type I
    5.3.2.2 Type II
  5.3.3 GlaxoSmithKline Plc. (UK) Venous Thromboembolism Sales, Revenue, Price and Gross Margin (2011-2016)
  5.3.4 Main Business/Business Overview
5.4 Boehringer Ingelheim (Germany)
  5.4.2 Venous Thromboembolism Product Type, Application and Specification
    5.4.2.1 Type I
    5.4.2.2 Type II
  5.4.3 Boehringer Ingelheim (Germany) Venous Thromboembolism Sales, Revenue, Price and Gross Margin (2011-2016)
  5.4.4 Main Business/Business Overview
5.5 Sanofi S.A. (France)
  5.5.2 Venous Thromboembolism Product Type, Application and Specification
    5.5.2.1 Type I
    5.5.2.2 Type II
  5.5.3 Sanofi S.A. (France) Venous Thromboembolism Sales, Revenue, Price and Gross Margin (2011-2016)
  5.5.4 Main Business/Business Overview
5.6 Abbott India Limited (India)
  5.6.2 Venous Thromboembolism Product Type, Application and Specification
    5.6.2.1 Type I
    5.6.2.2 Type II
  5.6.3 Abbott India Limited (India) Venous Thromboembolism Sales, Revenue, Price and Gross Margin (2011-2016)
  5.6.4 Main Business/Business Overview
5.7 Aspen Holdings (South Africa)
  5.7.2 Venous Thromboembolism Product Type, Application and Specification
    5.7.2.1 Type I
    5.7.2.2 Type II
  5.7.3 Aspen Holdings (South Africa) Venous Thromboembolism Sales, Revenue, Price and Gross Margin (2011-2016)
  5.7.4 Main Business/Business Overview
5.8 Bristol-Myers Squibb Company (US)
  5.8.2 Venous Thromboembolism Product Type, Application and Specification
    5.8.2.1 Type I
    5.8.2.2 Type II
  5.8.3 Bristol-Myers Squibb Company (US) Venous Thromboembolism Sales, Revenue, Price and Gross Margin (2011-2016)
  5.8.4 Main Business/Business Overview
5.9 Eisai Inc. (US)
  5.9.2 Venous Thromboembolism Product Type, Application and Specification
    5.9.2.1 Type I
    5.9.2.2 Type II
  5.9.3 Eisai Inc. (US) Venous Thromboembolism Sales, Revenue, Price and Gross Margin (2011-2016)
  5.9.4 Main Business/Business Overview
5.10 Mitsubishi Tanabe Pharma Corporation (Japan)
  5.10.2 Venous Thromboembolism Product Type, Application and Specification
    5.10.2.1 Type I
    5.10.2.2 Type II
  5.10.3 Mitsubishi Tanabe Pharma Corporation (Japan) Venous Thromboembolism Sales, Revenue, Price and Gross Margin (2011-2016)
  5.10.4 Main Business/Business Overview
5.11 Teva Pharmaceutical Industries Ltd. (Israel)

6 VENOUS THROMBOEMBOLISM MANUFACTURING COST ANALYSIS

6.1 Venous Thromboembolism Key Raw Materials Analysis
  6.1.1 Key Raw Materials
  6.1.2 Price Trend of Key Raw Materials
  6.1.3 Key Suppliers of Raw Materials
  6.1.4 Market Concentration Rate of Raw Materials
6.2 Proportion of Manufacturing Cost Structure
  6.2.1 Raw Materials
  6.2.2 Labor Cost
  6.2.3 Manufacturing Expenses
6.3 Manufacturing Process Analysis of Venous Thromboembolism

7 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

7.1 Venous Thromboembolism Industrial Chain Analysis
7.2 Upstream Raw Materials Sourcing
7.3 Raw Materials Sources of Venous Thromboembolism Major Manufacturers in 2015
7.4 Downstream Buyers

8 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

8.1 Marketing Channel
  8.1.1 Direct Marketing
  8.1.2 Indirect Marketing
  8.1.3 Marketing Channel Development Trend
8.2 Market Positioning
  8.2.1 Pricing Strategy
  8.2.2 Brand Strategy
  8.2.3 Target Client
8.3 Distributors/Traders List

9 MARKET EFFECT FACTORS ANALYSIS

9.1 Technology Progress/Risk
  9.1.1 Substitutes Threat
  9.1.2 Technology Progress in Related Industry
9.2 Consumer Needs/Customer Preference Change
9.3 Economic/Political Environmental Change

10 UNITED STATES VENOUS THROMBOEMBOLISM MARKET FORECAST (2016-2021)

10.1 United States Venous Thromboembolism Sales, Revenue Forecast (2016-2021)
10.2 United States Venous Thromboembolism Sales Forecast by Type (2016-2021)
10.3 United States Venous Thromboembolism Sales Forecast by Application (2016-2021)
10.4 Venous Thromboembolism Price Forecast (2016-2021)

11 RESEARCH FINDINGS AND CONCLUSION

12 APPENDIX

Author List
Disclosure Section
Research Methodology
Data Source
Disclaimer

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Venous Thromboembolism
Table Classification of Venous Thromboembolism
Figure United States Sales Market Share of Venous Thromboembolism by Type in 2015
Table Application of Venous Thromboembolism
Figure United States Sales Market Share of Venous Thromboembolism by Application in 2015
Figure United States Venous Thromboembolism Sales and Growth Rate (2011-2021)
Figure United States Venous Thromboembolism Revenue and Growth Rate (2011-2021)
Table United States Venous Thromboembolism Sales of Key Manufacturers (2015 and 2016)
Table United States Venous Thromboembolism Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Venous Thromboembolism Sales Share by Manufacturers
Figure 2016 Venous Thromboembolism Sales Share by Manufacturers
Table United States Venous Thromboembolism Revenue by Manufacturers (2015 and 2016)
Table United States Venous Thromboembolism Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Venous Thromboembolism Revenue Share by Manufacturers
Table 2016 United States Venous Thromboembolism Revenue Share by Manufacturers
Table United States Market Venous Thromboembolism Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Venous Thromboembolism Average Price of Key Manufacturers in 2015
Figure Venous Thromboembolism Market Share of Top 3 Manufacturers
Figure Venous Thromboembolism Market Share of Top 5 Manufacturers
Table United States Venous Thromboembolism Sales by Type (2011-2016)
Table United States Venous Thromboembolism Sales Share by Type (2011-2016)
Figure United States Venous Thromboembolism Sales Market Share by Type in 2015
Table United States Venous Thromboembolism Revenue and Market Share by Type (2011-2016)
Table United States Venous Thromboembolism Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Venous Thromboembolism by Type (2011-2016)
Table United States Venous Thromboembolism Price by Type (2011-2016)
Figure United States Venous Thromboembolism Sales Growth Rate by Type (2011-2016)
Table United States Venous Thromboembolism Sales by Application (2011-2016)
Table United States Venous Thromboembolism Sales Market Share by Application (2011-2016)
Figure United States Venous Thromboembolism Sales Market Share by Application in 2015
Table United States Venous Thromboembolism Sales Growth Rate by Application (2011-2016)
Figure United States Venous Thromboembolism Sales Growth Rate by Application (2011-2016)
Table Pfizer, Inc. (US) Basic Information List
Table Pfizer, Inc. (US) Venous Thromboembolism Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Pfizer, Inc. (US) Venous Thromboembolism Sales Market Share (2011-2016)
Table Bayer Healthcare AG (Germany) Basic Information List
Table Bayer Healthcare AG (Germany) Venous Thromboembolism Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bayer Healthcare AG (Germany) Venous Thromboembolism Sales Market Share (2011-2016)
Table GlaxoSmithKline Plc. (UK) Basic Information List
Table GlaxoSmithKline Plc. (UK) Venous Thromboembolism Sales, Revenue, Price and Gross Margin (2011-2016)
Table GlaxoSmithKline Plc. (UK) Venous Thromboembolism Sales Market Share (2011-2016)
Table Boehringer Ingelheim (Germany) Basic Information List
Table Boehringer Ingelheim (Germany) Venous Thromboembolism Sales, Revenue, Price and Gross Margin (2011-2016)
Table Boehringer Ingelheim (Germany) Venous Thromboembolism Sales Market Share (2011-2016)
Table Sanofi S.A. (France) Basic Information List
Table Sanofi S.A. (France) Venous Thromboembolism Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sanofi S.A. (France) Venous Thromboembolism Sales Market Share (2011-2016)
Table Abbott India Limited (India) Basic Information List
Table Abbott India Limited (India) Venous Thromboembolism Sales, Revenue, Price and Gross Margin (2011-2016)
Table Abbott India Limited (India) Venous Thromboembolism Sales Market Share (2011-2016)
Table Aspen Holdings (South Africa) Basic Information List
Table Aspen Holdings (South Africa) Venous Thromboembolism Sales, Revenue, Price and Gross Margin (2011-2016)
Table Aspen Holdings (South Africa) Venous Thromboembolism Sales Market Share (2011-2016)
Table Bristol-Myers Squibb Company (US) Basic Information List
Table Bristol-Myers Squibb Company (US) Venous Thromboembolism Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bristol-Myers Squibb Company (US) Venous Thromboembolism Sales Market Share (2011-2016)
Table Eisai Inc. (US) Basic Information List
Table Eisai Inc. (US) Venous Thromboembolism Sales, Revenue, Price and Gross Margin (2011-2016)
Table Eisai Inc. (US) Venous Thromboembolism Sales Market Share (2011-2016)
Table Mitsubishi Tanabe Pharma Corporation (Japan) Basic Information List
Table Mitsubishi Tanabe Pharma Corporation (Japan) Venous Thromboembolism Sales, Revenue, Price and Gross Margin (2011-2016)
Table Mitsubishi Tanabe Pharma Corporation (Japan) Venous Thromboembolism Sales Market Share (2011-2016)
Table Teva Pharmaceutical Industries Ltd. (Israel) Basic Information List
Table Teva Pharmaceutical Industries Ltd. (Israel) Venous Thromboembolism Sales, Revenue, Price and Gross Margin (2011-2016)
Table Teva Pharmaceutical Industries Ltd. (Israel) Venous Thromboembolism Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Venous Thromboembolism
Figure Manufacturing Process Analysis of Venous Thromboembolism
Figure Venous Thromboembolism Industrial Chain Analysis
Table Raw Materials Sources of Venous Thromboembolism Major Manufacturers in 2015
Table Major Buyers of Venous Thromboembolism
Table Distributors/Traders List
Figure United States Venous Thromboembolism Production and Growth Rate Forecast (2016-2021)
Figure United States Venous Thromboembolism Revenue and Growth Rate Forecast (2016-2021)
Table United States Venous Thromboembolism Production Forecast by Type (2016-2021)
Table United States Venous Thromboembolism Consumption Forecast by Application (2016-2021)